Sensorineural hearing loss associated with vincristine treatment-Reference-Cited by-同舟云学术

Sensorineural hearing loss associated with vincristine treatment

Published:1990-11 Issue:5 Volume:61 Page:320-321
ISSN:0006-5242
Container-title:Blut
language:en
Short-container-title:Blut

Author:

Lugassy G.,Shapira A.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/BF01732887.pdf

Reference6 articles.

1. Chauffert B, Lorcerie B, Andre F, Besaucenot JF, Martin F (1989) Vincristine-induced recurrent nerve paralysis during treatment of Hodgkin's disease. Presse Med 39: 1930–1931

2. Hirvonen HE, Salmi TT, Heinonen E, Antila KJ, Valimaki JAT (1989) Vincristine treatment of acute lymphoblastic leukemia induces transient autonomic cardioneuropathy. Cancer 64: 801–805

3. Legha SS (1986) Vincristine neurotoxicity. Pathophysiology and management. Med Toxicol Adverse Drug Exp 1: 421–427

4. Rosenthal S, Kaufman S (1947) Vincristine neurotoxicity. Ann Intern Med 80: 733–737

5. Sandler SG, Tobin W, Henderson ES (1969) Vincristine-induced neuropathy. Neurology 19: 367–374

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hearing loss after exposure to vincristine and platinum-based chemotherapy among childhood cancer survivors;2023-03-02

2. Hearing loss after exposure to vincristine and platinum-based chemotherapy among childhood cancer survivors;EJC Paediatric Oncology;2023

3. Ototoxicity Review: A Growing Number of Non–Platinum‐Based Chemo‐ and Immunotherapies;Otolaryngology–Head and Neck Surgery;2022-04-19

4. Neurological complications of systemic cancer and antineoplastic therapy;Neurological Complications of Systemic Cancer and Antineoplastic Therapy;2022

5. The cumulative incidence of cisplatin‐induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments;Cancer;2021-09-07